Kuzmin cited the absence of a pan-European stock market and the relatively modest size of UK-focused life sciences venture capital firms as key factors driving UK biotechs to sell to US buyers.

At some point in your research career, you may find yourself transitioning from academia to industry or vice versa. To best set yourself up for success, adapt your approach to the specific scientific ...

Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk ...

By Dare Ehigie AUSTIN, TX, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- A peer-reviewed study suggests that ...

For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Biotech Labz Supply has revealed an exciting enhancement of its product range, concentrating on research peptides that are gaining traction within the scientific community. As a prominent provider of ...

NINGBO, ZHEJIANG PROVINCE, CHINA, January 21, 2026 /EINPresswire.com/ -- In recent years, the global life science ...

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

A facility that manufactures products for pharmaceutical companies is set to eliminate one of its two Massachusetts ...